Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using domestic antiarrhythmic drug Refralon. Initial clinical results

Authors :: Yu. A. Yuricheva
L.V. Zinchenko
Vladislav Vlodzyanovsky
T. A. Malkina
L. Yu Laiovich
Kh. M. Dzaurova
Sergey P. Golitsyn
N. Yu. Mironov
D.A. Gagloeva
S. F. Sokolov
Source :: Kardiologicheskii vestnik. 16:49
Publication Year :: 2021
Publisher :: Media Sphere Publishing Group, 2021.

Subjects :: Protocol (science)
Drug
medicine.medical_specialty
business.industry
medicine.medical_treatment
media_common.quotation_subject
Atrial fibrillation
medicine.disease
Cardioversion
Internal medicine
Cardiology
Medicine
business
media_common

Full Text Access

Tools